Metrics
Publication
102
Open Access
7
UN Sustainable Development Goals
Education
2003 - 2009
2003 - 2009Doctorate
Dokuz Eylul University, Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik (Dr), Turkey
1993 - 1996
1993 - 1996Postgraduate
Dokuz Eylul University, Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik (Yl) (Tezli), Turkey
1987 - 1991
1987 - 1991Undergraduate
Dokuz Eylul University, Tıp Fakültesi, Tıbbi Biyolojik Bilimler Pr., Turkey
Dissertations
2009
2009Doctorate
Lösemik kök hücrelerde erken embriyonik kök hücre transkripsiyon faktörlerinin ekspresyonunun araştırılması
Dokuz Eylul University, Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik (Dr)
1996
1996Postgraduate
Uzun süreli kemik iliği kültürü çalışmaları ve kemik iliği hücrelerindeki kromozomal anomalilerin saptanması
Dokuz Eylul University, Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik (Yl) (Tezli)
Research Areas
Avesis Research Areas:
Medicine, Medical Biology, Health Sciences, Fundamental Medical Sciences
WoS Research Areas:
Clinical Medicine (Med), Life Sciences (Life), Clinical Medicine, Cell Biology, Molecular Biology & Genetics, Genetics & Heredity, Biochemistry & Molecular Biology
Scopus Research Areas:
Molecular Biology, Genetics, Cell Biology, General Biochemistry, Genetics and Molecular Biology
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
1998 - Present
1998 - PresentLecturer PhD
Dokuz Eylul University, Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı
Non Academic Experience
1996 - 1997
1996 - 1997Yedek subay
Gülhane Askeri Tıp Akademisi Biyokimya ABD, Yedek subay
Articles
All (55)
SCI-E, SSCI, AHCI (43)
SCI-E, SSCI, AHCI, ESCI (46)
ESCI (3)
Scopus (46)
TRDizin (16)
Other Publications (3)
2025
20251. The antidepressant sertraline impairs proliferation and invasiveness of human glioblastoma cells
Keles D., Inanc-Surer S., Sipahi M., Erkan E. P., ATEŞ H., Erbayraktar Z., et al.
FEBS OPEN BIO , vol.15, pp.228, 2025 (SCI-Expanded, Scopus)
2025
20252. Isolation and efficiency assessment of adipose-derived mesenchymal stem cells
YILDIRIM A., Silistreli A. O., Bildik E., ATEŞ H., KOÇDOR H.
FEBS OPEN BIO , vol.15, pp.80, 2025 (SCI-Expanded, Scopus)
2025
20253. Impact of enzymatic isolation on the propagation efficiency of patient-derived colorectal cancer organoids.
Calibasi-Kocal G., Sever T., Canda A. E., Kadioglu L. E., Ates H., Basbinar Y., et al.
Scientific reports
, vol.15, no.1, pp.13452, 2025 (SCI-Expanded, Scopus)
2025
20254. Casticin inhibits the hedgehog signaling and leads to apoptosis in AML stem-like KG1a and mature KG1 cells
Dogru T. E., Gulfidan G., ATEŞ H., ARGA K. Y., KOÇTÜRK A. S.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, vol.50, no.1, pp.62-72, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20255. Hydroxyapatite and Loofah-Reinforced Carboxymethyl Chitosan Hydrogel Scaffold with/without Stem Cells for Bone Healing: In Vitro and In Vivo
TÜREMİŞ C., Baysan G., Aydemir S., ÇOLPANKAN GÜNEŞ O., Husemoglu R. B., ATEŞ H., et al.
Biomedical Materials and Devices , 2025 (Scopus)
2025
20256. Effects of 27.12 MHz short-waves on fibroblast cell culture and K-562 and ML-1 neoplastic cell lines
Muluk S. Y., ÖZSAN G. H., Öncel S., ATEŞ H.
Turkish Journal of Physical Medicine and Rehabilitation , vol.71, no.1, pp.83-91, 2025 (SCI-Expanded, Scopus, TRDizin)
2024
20247. Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates
Yücesoy E., Demir Yenigürbüz F., ATEŞ H., Tüzün F., DUMAN N., Özkan H., et al.
Blood Coagulation and Fibrinolysis , vol.35, no.5, pp.227-231, 2024 (SCI-Expanded, Scopus)
2023
20238. Investigation of the in vitro effects of mitochondrial-derived peptide (MOTS-c) on imatinib-resistant chronic myeloid leukemia model
Yalçın P., Kızıldağ S., Ateş H., Yüce Z., Baykal Köse S.
The Injector
, vol.2, no.3, pp.108, 2023 (Peer-Reviewed Journal)
2023
20239. Does Combination of DNR and Casticin show advantage in favor of apoptosis on AML leukemia stem-like cell lines? A preliminary study
Erkmen T., ATEŞ H., KOÇTÜRK A. S.
JOURNAL OF RESEARCH IN PHARMACY
, vol.27, no.3, pp.1270-1288, 2023 (ESCI, Scopus, TRDizin)
2022
202210. COMPARISON OF THE EFFECTS OF PISTACIA VERA INNER SHELL OBTAINED FROM DIFFERENT REGIONS OF TURKEY ON OXIDATIVE STRESS AND PROLIFERATION IN INVASIVE BREAST CANCER CELL LINE
Gürkebabcı İ., Koçdor B., Ateş H., Koçdor H.
TURKISH JOURNAL OF BIOCHEMISTRY
, vol.47, no.1, pp.71-77, 2022 (SCI-Expanded, Scopus)
2022
202211. Borax Pentahydrate and Disodium Pentaborate Decahydrate Are Candidates as Anti-leukemic Drug Components by Inducing Apoptosis and Changing Bax/Bcl-2 Ratio in HL-60 Cell Line.
Erkmen T., Serdar B. S., Ateş H., Korkmaz M., Koçtürk A. S.
Biological trace element research
, vol.200, no.4, pp.1608-1616, 2022 (SCI-Expanded, Scopus)
2021
202112. KML VE KML LÖSEMİK KÖK HÜCRESİ ARASINDA MİKRORNA EKSPRESYON DEĞİŞİMLERİNİN DEĞERLENDİRİLMESİ
Pehlivan M., Soyöz M., Karahan İ., Çerçi Gürbüz B., Kılıçaslan Ayna T., Ateş H., et al.
SDÜ Tıp Fakültesi Dergisi , vol.27, no.3, pp.315-321, 2021 (TRDizin)
2021
202113. ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IS REGULATED BY SP1 TRANSCRIPTION FACTOR IN MURINE MICROGLIA
Tüfekci K. U., Ateş H., Genç Ş.
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
, vol.5, no.1, pp.6-13, 2021 (ESCI)
2020
202014. Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells
Baykal-Kose S., Açıkgöz E., Yavuz A. S., Geyik O. G., Ateş H., Sezerman O. U., et al.
PLOS ONE
, vol.15, no.2, 2020 (SCI-Expanded, Scopus)
2020
202015. Casticin: A Promising Candidate to Develop a Stem Cell Targeted Strategy in AML Treatment
Erkmen T., Serdar B. S., Ateş H., Keskinoğlu P., Kocturk S.
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.4, no.3, pp.297-304, 2020 (ESCI, TRDizin)
2019
201916. Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy.
Yenigurbuz F. D., Kizmazoglu D., Ateş H., Erdem M., Tüfekçi Ö., Yılmaz Ş., et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.30, no.4, pp.149-155, 2019 (SCI-Expanded, Scopus)
2019
201917. Can Inflammatory and Nutritional Serum Markers Predict Chemotherapy Outcomes and Survival in Advanced Stage Nonsmall Cell Lung Cancer Patients?
Cehreli R., Yavuzşen T., Ateş H., Akman T., Ellidokuz H., Öztop İ.
BIOMED RESEARCH INTERNATIONAL
, vol.2019, 2019 (SCI-Expanded, Scopus)
2019
201918. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells
Koçdor M. A., Cengiz H., Ateş H., Koçdor H.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
, vol.19, no.15, pp.1887-1898, 2019 (SCI-Expanded, Scopus)
2016
201619. Corneal recovery in a rabbit limbal stem cell deficiency model by autologous grafts of tertiary outgrowths from cultivated limbal biopsy explants
Barut Selver Ö., Durak İ., Gurdal M., Baysal K., Ateş H., Özbek Z., et al.
MOLECULAR VISION , vol.22, pp.138-149, 2016 (SCI-Expanded, Scopus)
2015
201520. Demir Sükroz Ve Demir Dekstran ın Sıçanlarda Periferik Kanda Lenfosit Dağılım Ve İşlevleri Üzerine Olan Etkilerinin Araştırılması
Sert M., Ateş H., Çavdar Z., Yüksel Eğrilmez M., Çelik A., Çavdar C., et al.
DEU Tıp Fakültesi Dergisi
, vol.28, no.3, pp.105-112, 2015 (Peer-Reviewed Journal)
2015
201521. Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer
Koçdor H., Ateş H., Aydın S., Cehreli R., Soyarat F., Kemanli P., et al.
DRUG DESIGN DEVELOPMENT AND THERAPY
, vol.9, 2015 (SCI-Expanded, Scopus)
2014
201422. Demir sükroz ve demir dekstran ın sıçanlarda periferik kanda lenfosit dağılım ve işlevleri üzerine olan etkilerinin karşılaştırılması
Sert M., Ateş H., Çavdar Z., Yüksel Eğrilmez M., Çelik A., Çavdar C., et al.
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
, vol.28, no.3, pp.105-112, 2014 (TRDizin)
2014
201423. Ser159 mutation of the pre-initiation complex protein TAF7 CAUSES A G2/M block in cell cycle
Gokturk D., Ateş H., Sercan Z.
Turkish Journal of Biochemistry-Turk Biyokimya Dergisi , vol.39, no.4, pp.516-522, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201424. Mast cell leukemia associated with undefined morphology and chronic basophilic leukemia
Cehreli C., Alacacıoğlu İ., Piskin O., Ateş H., Cehreli R., Calibasi G., et al.
BMC Hematology
, vol.14, no.1, 2014 (Scopus)
2013
201325. TLR-4 polymorphisms and leukocyte TLR-4 expression in febrile UTI and renal scarring
Torun Bayram M., Soylu A., Ateş H., Kızıldağ S., Kavukçu S.
PEDIATRIC NEPHROLOGY , vol.28, no.9, pp.1827-1835, 2013 (SCI-Expanded, Scopus)
2013
201326. New paraneoplastic syndrome in chronic basophilic leukemia.
Cehreli C., Ateş H., Cehreli R., Sercan Z., Demirkan F.
International journal of hematology , vol.97, no.4, pp.498-504, 2013 (SCI-Expanded, Scopus)
2012
201227. EVALUATION OF THE RATE OF TLR-4 ASP299GLY AND THRE399ILE POLYMORPHISIMS AND LEUKOCYTE TLR-4 EXPRESSION LEVELS IN PATIENTS WITH AND WITHOUT POSTPYELONEPHRITIC RENAL SCARRING
Torun Bayram M., Soylu A., Ateş H., Kızıldağ S., Turkmen M. A., Kavukçu S.
PEDIATRIC NEPHROLOGY , vol.27, no.9, pp.1747, 2012 (SCI-Expanded, Scopus)
2012
201228. Evaluation of Circulating Endothelial and Platelet Microparticles in Men with Ankylosing Spondylitis
Sarı İ., Bozkaya G., Kirbiyik H., Alacacioglu A., Ateş H., Sop G., et al.
JOURNAL OF RHEUMATOLOGY , vol.39, no.3, pp.594-599, 2012 (SCI-Expanded, Scopus)
2011
201129. TLR Polymorphisms in FMF: Association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) Polymorphisms and Myeloid Cell TLR-2 and TLR-4 Expression with the Development of Secondary Amyloidosis in FMF
Soylu A., Ateş H., Cingöz S., Turkmen M., Demir B. K., Tunca M., et al.
INFLAMMATION
, vol.34, no.5, pp.379-387, 2011 (SCI-Expanded, Scopus)
2011
201130. The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma
Erçetin A. P., Aktaş S., Piskin O., Ateş H., Zadeoglulari Z. F., Turgut N. H., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.28, no.2, pp.107-114, 2011 (SCI-Expanded, Scopus, TRDizin)
2010
201031. Treatment of K562 cells with 1,25-dihydroxyvitamin D-3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21
Kızıldağ S., Ateş H., Kızıldağ S.
ANNALS OF HEMATOLOGY
, vol.89, no.1, pp.1-7, 2010 (SCI-Expanded, Scopus)
2010
201032. Discrimination Effectiveness of CK18 on Cell Death Modes in Colon Cancer Cells
Altun Z. S., Akhisaroglu S. T., Batu J., Ateş H., Giray H., Kocturk S.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, vol.35, no.1, pp.20-28, 2010 (SCI-Expanded, Scopus, TRDizin)
2009
200933. APOPTOTIC EFFECT OF (-)-EPIGALLOCATECHIN-3-GALLATE ON HCT-116 COLON CARCINOMA CELLS
Ozkaya A. B., Akpinar B., Ateş H., Altun Z. S., Kocturk S.
IUBMB LIFE , vol.61, no.3, pp.325, 2009 (SCI-Expanded, Scopus)
2009
200934. AN IN-VITRO STUDY TO EVALUATE THE SIGNIFICANCE OF CK-18 ON DETERMINATION OF CELL DEATH MODES TOWARD CHEMOTHERAPEUTICS IN HUMAN COLON CANCER CELL LINE
Altun Z. S., Tanriverdi-Akhisaroglu S., Batu J., Ateş H., Giray H., Kocturk S.
IUBMB LIFE
, vol.61, no.3, pp.388, 2009 (SCI-Expanded, Scopus)
2008
200835. Cytokeratin 18 in Determining Cytotoxicity of Folfox and Folfiri Chemotherapy Regimens in Colon Carcinoma Cells
Altun Z. S., Batu J., Ateş H., Şimşek Keskin H., Koçtürk A. S.
CYTOMETRY PART B - CLINICAL CYTOMETRY , vol.74, no.6, pp.401-402, 2008 (SCI-Expanded)
2008
200836. TLR-2 and TLR-4 polymorphisms and TLR-2 and TLR-4 expression in leukocytes in FMF patients with and without amyloidosis
Soylu A., Ateş H., Cingöz S., Turkmen M. A., Kasap B., Tunca M., et al.
PEDIATRIC NEPHROLOGY , vol.23, no.9, pp.1624, 2008 (SCI-Expanded, Scopus)
2008
200837. Erythroid apoptosis in idiopathic neonatal jaundice
Özkan H., Ören H., Tatli M., Ateş H., Kumral A., Duman N.
PEDIATRICS , vol.121, no.5, 2008 (SCI-Expanded, Scopus)
2007
200738. Reticulated platelet levels in patients with ulcerative colitis
Kayahan H., Akarsu M., Ozcan M. A., Demir S., Ateş H., Unsal B., et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , vol.22, no.12, pp.1429-1435, 2007 (SCI-Expanded, Scopus)
2007
200739. Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines
Sercan H. O., Pehlivan M., Simsek Ö., Ateş H., Sercan Z.
ONCOLOGY REPORTS , vol.18, no.6, pp.1563-1569, 2007 (SCI-Expanded, Scopus)
2007
200740. Synergistic effect of imatinib mesylate and fludarabine combination on Philadelphia chromosome-positive chronic myeloid leukemia cell lines
Pişkin Ö., Özcan M., Özsan G. H., Ateş H., Demirkan F., Alacacıoğlu İ., et al.
Turkish Journal of Hematology , vol.24, no.1, pp.23-27, 2007 (SCI-Expanded, Scopus, TRDizin)
2007
200741. (99)'Tc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC-NC cells
Ulker O., Genç Ş., Ateş H., Durak H., Atabey N.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS , vol.631, no.2, pp.69-76, 2007 (SCI-Expanded, Scopus)
2006
200642. The effect of imatinib mesylate on the erythroid colony formation from patients with polycythemia vera in the presence of different cytokines
Pişkin Ö., Özsan G. H., Ateş H., Özcan M. A., Demirkan F., Alacacıoğlu İ., et al.
Turkish Journal of Hematology , vol.23, no.3, pp.136-141, 2006 (SCI-Expanded, Scopus)
2006
200643. Circulated activated platelets and increased platelet reactivity in patients with Behcet's disease
Akar S., Oezcan M. A., Ateş H., Guerler O., Alacacioglu İ., Oezsan G. H., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, vol.12, no.4, pp.451-457, 2006 (SCI-Expanded, Scopus)
2006
200644. Erythropoietin decreases apoptosis induced by 6-hydroxydopamine in PC12 cells
Genç Ş., Ay M. E., Ateş H.
Turk Geriatri Dergisi , vol.9, no.1, pp.13-18, 2006 (SCI-Expanded, Scopus, TRDizin)
2005
200545. Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines.
Vural F., Ozcan M., Ozsan G. H., Ateş H., Demirkan F., Piskin O., et al.
Leukemia & lymphoma , vol.46, no.5, pp.753-6, 2005 (SCI-Expanded, Scopus)
2004
200446. Plasma tissue factor levels in patients with colon cancer receiving infusional 5-fluorouracil chemotherapy İnfüzyonel 5-fluorourasil kemoterapisi alan kolon kanserli hastalarda plazma doku faktörü düzeyleri
ÖZTOP İ., ATEŞ H., ALACACIOĞLU A., Yaren A., TARHAN M. O., Alakavuklar M., et al.
THOD - Turk Hematoloji-Onkoloji Dergisi , vol.14, no.3, pp.147-152, 2004 (Scopus, TRDizin)
2004
200447. İnfüzyonel 5 Fluorourasil kemoterapisi Alan Kolon Kanserli Hastalarda Plazma Doku Faktörleri Düzeyleri
Öztop İ., Ateş H., Alacacıoğlu A., Yaren A., Tarhan M. O., Alakavuklar M., et al.
TÜRK HEMATOLOJİ-ONKOLOJİ DERGİSİ
, vol.14, no.3, pp.147-152, 2004 (Peer-Reviewed Journal)
2004
200448. Gingival involvement in a patient with CD56+ chronic myelomonocytic leukemia
Vural F., Ozcan M. A., Ozsan G. H., Demirkan F., Piskin O., Ateş H., et al.
LEUKEMIA & LYMPHOMA
, vol.45, no.2, pp.415-418, 2004 (SCI-Expanded)
2003
200349. Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura
Ucar C., Oren H., Irken G., Ateş H., Atabay B., Turker M., et al.
EUROPEAN JOURNAL OF HAEMATOLOGY , vol.70, no.6, pp.347-352, 2003 (SCI-Expanded, Scopus)
2003
200350. Neutrophil apoptosis in patients with beta-thalassemia major
Oren H., Sahin B., Iken G., Ateş H., Duman M., Yilmaz Ş., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.20, no.3, pp.237-243, 2003 (SCI-Expanded, Scopus)
2003
200351. Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia
Genc Ş., Kizyldag S., Genc K., Ateş H., Atabey N.
IMMUNOLOGY LETTERS , vol.85, no.3, pp.271-274, 2003 (SCI-Expanded, Scopus)
2003
200352. Neutrophil apoptosis in patients with β-thalassemia major
ÖREN H., Şahin B., Irken G., ATEŞ H., DUMAN M., YILMAZ Ş., et al.
Pediatric Hematology and Oncology , vol.20, no.3, pp.237-243, 2003 (SCI-Expanded, Scopus)
2001
200153. Effect of sialic acid on platelet cryopreservation
Özsan G. H., Pişkin Ö., Demirkan F., Ateş H., Özcan M., Ündar B.
Turkish Journal of Haematology , vol.18, no.4, pp.251-257, 2001 (SCI-Expanded, Scopus, TRDizin)
2000
200054. Evaluation of peripheral blood platelet activation and leukocyte-platelet aggregates in relation to disease activity in inflamatory bowel disease.
Öztop İ., Özsan :. H., Ateş H., Çabuk M., Demirkan F., Ündar B.
Türk Hematoloji Onkoloji Dergisi , vol.10, no.3, pp.144-150, 2000 (TRDizin)
1999
199955. The Role of Interleukin-1 Inhibitors on Acute Myeloblastic Leukemia Blast Proliferation; Future Potential for Biotherapy.
Çehreli C., Özsan G. H., Demirkan F., Ateş H., Ündar B., Akyol F., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.16, no.4, pp.161-6, 1999 (SCI-Expanded, Scopus, TRDizin)
Papers Presented at Peer-Reviewed Scientific Conferences
2023
20231. İmatinib Dirençli Kronik Myeloid Lösemi Modelinde Mitokondriyal-Türevli Peptid (MOTS-c)’in in vitro Etkilerinin Araştırılması
Yalçın P., Kızıldağ S., Ateş H., Yüce Z., Baykal Köse S.
18.Tıbbi Biyoloji ve Genetik Kongresi, Ankara, Turkey, 26 - 29 October 2023, pp.131, (Summary Text)
2022
20222. CASTICIN: A PROMISING CANDIDATE TO DEVELOP A STEM CELL TARGETED STRATEGY IN AML TREATMENT
Erkmen T., Sert Serdar B., Ateş H., Keskinoğlu P., Koçtürk A. S.
4TH CONGRESS OF CELL DEATH RESEARCH SOCIETY-TURKIYE WITH INTERNATIONAL PARTICIOATION, İzmir, Turkey, 17 - 19 March 2022, pp.47, (Summary Text)
2021
20213. Casticin: a promising candidate to develop a stem cell targeted strategy in AML treatment
ERKMEN T., SERT SERDAR B., ATEŞ H., KESKİNOĞLU P., KOÇTÜRK A. S.
3rd International Cancer and Ion Channels Congress, Turkey, 16 September 2021, (Summary Text)
2019
20194. Investigation of the relationship between cellular adaptation and therapeutic resistance in chronic myeloid leukemia cells under imatinib pressure
Baykal Köse S., Yavuz S., AÇIKGÖZ E., GÖNÜL GEYİK Ö., ATEŞ H., SEZERMAN O. U., et al.
1st INTERNATIONAL MULTIDISCIPLINARY CANCER RESEARCH CONGRESS, 18 - 22 September 2019, (Summary Text)
2019
20195. The effect of hyperbilirubinemia and phototherapy on apoptotic platelet derived, endothelial derived, and tissue factor positive microparticle levels in neonates
Yücesoy E., DEMİR YENİGÜRBÜZ F., ATEŞ H., TÜZÜN F., DUMAN N., ÖZKAN H., et al.
XXVII. Congress of the International Society on Thrombosis and Haemostasis, 6 - 10 July 2019, (Summary Text)
2019
20196. An Adaptive Phenotypic Shift Leads to TKI Resistance by Acquisition Of Leukemic Stem Cell-Like Properties in CML Cells
YÜCE Z., Baykal Köse S., GÖNÜL GEYİK Ö., Yavuz A. S., AÇIKGÖZ E., ATEŞ H., et al.
2nd İstanbul Immunohematology Summit, 2 - 04 May 2019, (Summary Text)
2019
20197. Yenidoğanlarda Hiperbilirubinemi ve Fototerapinin Apoptik, Endotel-Kaynaklı, Trombosit-Kaynaklı ve Doku Faktörü Pozitif Mikropartiküller Üzerine Etkisi
YÜCESOY E., DEMİR YENİGÜRBÜZ F., ATEŞ H., TÜZÜN F., DUMAN N., ÖZKAN H., et al.
12. ULUSAL PEDİATRİK HEMATOLOJİ KONGRESİ, Konya, Turkey, 24 - 27 April 2019, pp.93, (Full Text)
2019
20198. KML ve KML Kanser Kök Hücrelerindeki MikroRNA ekspresyon profillerinin karşılaştırılması
PEHLİVAN M., SOYÖZ M., Karahan H. İ., ÇERÇİ GÜRBÜZ B., KILIÇASLAN AYNA T., ATEŞ H., et al.
Uluslararası Hipokrat Tıp ve Sağlık Bilimleri Kongresi, Ankara, Turkey, 1 - 03 March 2019, pp.64-65, (Summary Text)
2018
20189. Apoptotic Effect of Boron Derivatives on HL-60 AcutePromyelocytic Leukemia Cell Line
ERKMEN T., SERT B., ATEŞ H., KORKMAZ M., KOÇTÜRK A. S.
2nd International Cell Death Research Congress, Basel, Switzerland, 1 - 04 November 2018, vol.2, pp.1533-1537, (Full Text)
2018
201810. Deguelin and Curcumin have potential to reverse tumor aggressiveness in Anaplastic Thyroid Cancer
CENGİZ H., KOÇDOR M. A., ATEŞ H., KOÇDOR H.
3. Türkiye in vitro Diyagnostik Sempozyumu Endokrin ve Metabolik Hastalıklar Tanıdan Tedaviye Biyobelirteçler, İzmir, Turkey, 28 February - 02 March 2018, vol.43, pp.28, (Summary Text)
2018
201811. OTOLOG NAKİL YAPILAN MULTİPL MYELOMHASTALARINDA REİNFÜZYON GÜN SAYISININENGRAFMANA VE HASTANEDE KALIŞ SÜRESİNE ETKİSİ
SOLMAZ Ş., TÜRKYILMAZ D., ACAR C., SEVİNDİK Ö. G., YİĞİT KAYA S., ACAR A., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2018, (Summary Text)
2017
201712. EFFECTIVENESS OF DEGUELIN ON in vitro ANTI-CANCER MARKER IN PANCREAS AND PROSTATE CANCERS
Ceylan Kılıç Z., CENGİZ H., YENER N., KOÇDOR M. A., ATEŞ H., salman t., et al.
1. Uluslararası Biyokimya Kongresi, Germany, 19 - 23 September 2017, vol.42, pp.39, (Summary Text)
2017
201713. DEGUELIN’S EFFICACY IN in vitro ANTI-CANCER MARKER
çelebi s., ghanitabe n., CENGİZ H., ATEŞ H., salman t., KOÇDOR M. A., et al.
2.IVD Semp., 10 - 12 May 2017, vol.42, pp.64, (Summary Text)
2017
201714. DEGUELIN’S EFFICACY IN in vitro ANTI-CANCER MARKER IN LUNG CANCER
ghanitabe n., çelebi s., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.
2. IVD Semp., 10 - 12 May 2017, (Summary Text)
2017
201715. Bcr-ABL pozitif hücrelerdeizlenen imatinib direncinde otofajil hücre ölüm yolağı baskılanmaktadır
YÜCE Z., ATEŞ H., BAYKAL S., ÖZSAN G. H.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Full Text)
2017
201716. Akut lenfoblastik lösemili çocuklarda indüksiyonda, doku faktörü pozitif, trombosit, endotel kaynaklı mikropartikül düzeyleri
YENİGÜRBÜZ DEMİR F., KIZMAZOĞLU D., ATEŞ H., ERDEM M., TÜFEKÇİ Ö., YILMAZ Ş., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201717. BCR-ABL pozitif hücrelerde izlenen İmatinib direncinde otofajik hücre ölüm yolağı baskılanmaktadır.
YÜCE Z., BAYKAL S., Geyik Ö. G., ATEŞ H., Efe H., ÖZSAN G. H.
43. Ulusal Hemtoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2016
201618. ANTI CANCER EFFICACY OF DEGUELIN AGAINST LUNG CANCER CELLS WITH AND WITHOUT DOCETAXEL
Çelebi S., Ghanitabe N., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.
1.Cell Death Congress, 4 - 07 May 2016, (Summary Text)
2016
201619. THE IMPORTANCE OF RESVERATROL IN POINT OF P53 MUTATION AND SIRT1 ACTIVITY OF COLORECTAL CANCER CELLS
ÖZEN G., SERT SERDAR B., ATEŞ H., KOÇTÜRK A. S.
1ST INTERNATIONAL CELL DEATH RESESEARCH CONGRESS, İzmir, Turkey, 4 - 07 May 2016, vol.41, pp.87-91, (Full Text)
2016
201620. Anti cancer efficacy of deguelin against lungcancer cells
ÇELEBİ S., GHANITABE N., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.
1.CELL DEATH CONGRESS, 4 - 07 May 2016, (Summary Text)
2016
201621. Selenium pre-treatment increases the efficacy of standard chemotherapy regimens in lung cancer
Cengiz H., Kocdor H., Ghanitabe N., Celebi S., Ates H., Egrilmez M., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.250, (Summary Text)
2016
201622. Effects of tyrosine kinase inhibitor Imatinib onautophagy in BCR ABL positive leukemia cells
BAYKAL S., Öykü Gönül G., ATEŞ H., Efe H., YÜCE Z.
41 th FEBS Congress, 3 - 08 September 2016, vol.283, pp.431, (Full Text)
2016
201623. Anti-cancer efficacy of deguelin against lung cancer cells with and without docetaxel and cisplatine
Beyoglu G. G., Ghanitabe N., Celebi S., Cengiz H., Ates H., Egrilmez M., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.250, (Summary Text)
2016
201624. Leukemic cell plasticiy as a resistance mechanism towards tyrosine kinase inhibitors
Baykal S., Ates H., Yavuz A. S., Sezerman U., Acikgoz E., Oktem G., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.298, (Summary Text)
2016
201625. The effects of resveratrol gain importance according to p53 mutation in HCT116 colon cancer cell lines
Ozen G., Serdar B. S., Ates H., Kocturk A. S.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.260-261, (Summary Text)
2016
201626. Cytotoxic effects of boron compounds in P53 (+/+) and P53 (-/-) HCT-116 colon carcinoma cells lines
Serdar B. S., Ozen G., Gunay I. C., Korkmaz M., Ates H., Kocturk A. S.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.262, (Summary Text)
2016
201627. RESVERATROL CAN EFFECT CELL FATE DIFFERENTLY RELATED WITH P53 MUTATION ANDSIRT1 ACTIVITY LEVEL OF HCT116 COLON CARCINOMA CELLS
ÖZEN G., SERDAR SERT B., ATEŞ H., KOÇTÜRK A. S.
1st International Cell Death Research Congress-Turkey, İzmir, Turkey, 4 - 07 May 2016, (Summary Text)
2016
201628. THE EFFECTS OF RESVERATROL GAIN IMPORTANCE ACCORDING TO P53 MUTATION INHCT116 COLON CANCER CELL LINES
ÖZEN G., SERT SERDAR B., ATEŞ H., KOÇTÜRK A. S.
1st International Cell Death Research Congress-Turkey, İzmir, Turkey, 4 - 07 May 2016, (Summary Text)
2015
201529. ANTI CANCER EFFICACY OF DEGUELIN AGAINST LUNGCANCER CELLS WITH AND WITHOUT DOCETAKSEL
çelebi s., ghanitabe n., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.
27. Ulusal Biyokimya Kongresi, Antalya [27th National Biochemistry Congress, Antalya, 3 - 06 November 2015, (Summary Text)
2015
201530. Deneysel Limbal Kök Hücre Yetmezliği Hayvan Modelinde Limbal Biyopsiden Üretilen Epitelyal Kök Hücre ültürlerinin Pasajlanmasının Oküler Yüzey Rejenerasyonu Üzerine etkinliğinin değerlendirilmesi
DURAK İ., BARUT SELVER Ö., GÜRDAL M., BAYSAL K., ÖZBEK Z., ATEŞ H., et al.
TOD 49. Ulusal Kongresi, İstanbul, Turkey, 4 - 08 November 2015, (Full Text)
2015
201531. Endothelial protein C receptor expression in microglia is regulated by Sp1
Tufekci K. U., Eren E., ATEŞ H., GENÇ Ş.
12th European Meeting on Glial Cell Function in Health and Disease, Bilbao, Spain, 15 - 18 July 2015, vol.63, (Summary Text)
2015
201532. Zınc supplementation exhibits anti tumor efficacy and enhances docetaxel induced cytotoxicity in lung and hormone resistant prostate cancer cells
KOÇDOR H., ATEŞ H., CENGİZ H., AYDIN S., ÇEHRELİ R., ÇEHRELİ R., et al.
EACR Sponsored 3rd Anticancer Agent Development Congress, 18 - 19 May 2015
2015
201533. The importance of p53 and SIRT 1 in apoptotic effects of resveratrol in HCT 116 colon carcinoma cell line
ÖZEN G., ATEŞ H., KOÇTÜRK A. S.
3rd Anticancer Agent Development Congress, 18 - 19 May 2015
2015
201534. Kronik Miyeloid Lösemide Wif1 Proteininin Tedavi Direncinin Aşılmasına Etkisi
PEHLİVAN M., Ceyda Ç., ATEŞ H., Feriha Ö., YÜCE Z., SERCAN H. O.
II Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Turkey, 16 - 19 April 2015, (Summary Text)
2013
201335. P-149 - THE ANTICANCER EFFICACY OF ZINC SUPPLEMENTATION INTO STANDART REGIMENS AGAINST ANDROGEN RECEPTOR NEGATİVE PROSTATE CANCER CELL LINES
Koçdor H., Çehreli R., Soyarat F., Ateş H., Kemanlı P., Özsan G. H., et al.
XXV. ULUSAL BİYOKİMYA KONGRESİ, İzmir, Turkey, 3 - 06 September 2013, pp.265, (Summary Text)
2013
201336. Effects of Letrozole and Radiotherapy on Cell Cycle and Death in a Breast Cancer Cell Line
DURMAK İŞMAN B., GÖKTÜRK D., YÜCE Z., ATEŞ H., KARAGÜLER Z., GÖRKEN İ.
American Association for Cancer Researh Annual Meating, Washington, Kiribati, 6 - 10 April 2013, (Summary Text)
2012
201237. Study of the Effect of Concurrent Use of Letrozole with Radiotherapy to the Cell Death Mechanisms in the Breast Cancer Cell Line
Isman B. D., Gokturk D., Sercan Z., Karaguler Z., ATEŞ H., Gorken İ.
8th European Breast Cancer Conference (EBCC), Vienna, Austria, 21 - 24 March 2012, vol.48, (Summary Text)
2011
201138. Radyoterapi ile eşzamanlı Letrozol kullanımının meme kanseri hücre hattında hücre ölüm mekanizmaları üzerine etkilerinin araştırılması
DURMAK İŞMAN B., GÖRKEN İ., GÖKTÜRK D., ATEŞ H., KARAGÜLER Z., YÜCE Z.
XI. Ulusal Meme Hastalıkları Kongresi, Antalya, Turkey, 5 October - 09 September 2011, (Summary Text)
2011
201139. Evaluation of Circulating Endothelial and Platelet Microparticles In Men with Ankylosing Spondylitis
SARI İ., Bozkaya G., Kirbiyik H., Alacacioglu A., ATEŞ H., Sop G., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, United States Of America, 4 - 09 November 2011, vol.63, (Summary Text)
2008
200840. CYTOKERATIN 18 IN DETERMINING CYTOTOXICITY OF FOLFOX AND FOLFIRI CHEMOTHERAPY REGIMES IN COLON CARCINOMA CELLS
Tanriverdi-Akhisaroglu S., ALTUN Z. S., Batu J., ATEŞ H., Giray H., Kocturk S.
23rd Annual Meeting of the Clinical-Cytometry-Society, Oregon, United States Of America, 12 - 14 October 2008, vol.74B, pp.401-402, (Summary Text)
2007
200741. Polilaktikasit kaplı kollajen jel yapı iskeletine ekilen osteoblastlara tek yönlü ve devirli makanik gerne uyarımı
ÖZCANHAN M. H., MUTLU İ., ATEŞ H., İNCİ İ., ERCAN U. K., ÇEÇEN B., et al.
XX. Milli Türk Ortopedi ve Travmatoloji Kongresi, Ankara, Turkey, 23 - 28 October 2007, vol.41, pp.26
2004
200442. Potential İnteractions Between Neutrophil Apoptosis and Oxidative Damage in Familial Mediterraen Fever FMF
Kırkalı G., Dizdaroğlu M., RESMİ H., Özsan H., TUNCEL E. P., ATEŞ H., et al.
4th İntenational Congress on Systemic Autoinflammatory Diseases, Bethesda, Maryland, USA, 06 November 2004 - 10 November 2006
2006
200643. Metastatik Meme Kanserli Hastalarda İnflamatuar Sitokin Akut Faz Reaktanları Hematolojik Parametreler Bioelektrik İmpedans Analizleri ve Üç Kür Epirubisin ve Dosetaksel Tedavisiyle Alınan Yanıta Etkisi
BAŞKAN Z., DEMİRKAN H. M. B., ATEŞ H., DEMİR T., GÜRSOY ÇALAN Ö., İŞLEKEL G. H., et al.
3. Ulusal Tıbbi Onkoloji Kongresi, Turkey, 6 - 10 September 2006
2006
200644. Serum levels of inflamatuar cytokine and acute phase reactants, hematological parameters, bioelectric impedance analysis and their relation to therapeutic response in metastatic breast cancer patients who received epirubicin & docetaxel chemotherapy
Baskan Z., Demirkan B., ATEŞ H., Demir T., Calan Ö., Islekel H., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.89-90, (Summary Text)
2004
200445. The effects of Tc-99m HMPAO labeling on lymphocyte functions
Ulker O., Genc Ş., Ates H., Durak H., Atabey N.
17th Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finland, 4 - 08 September 2004, vol.31, (Summary Text)
2004
200446. İnfuzyonel 5 flurourasii kemoterapisi alan kolon kanserli hastalarda plazma doku faktörü düzeyleri
ÖZTOP İ., ATEŞ H., ALACACIOĞLU A., YAREN A., TARHAN M. O., ALAKAVUKLAR M., et al.
Ulusal Tıbbi Onkoloji Kongresi, Antalya, Turkey, 15 - 18 April 2004
Memberships and Roles in Scientific Organizations
2013 - Present
2013 - PresentTürk Hematoloji Derneği
Member
Scientific Project Refereeing
January 2023
January 2023Project Supported by Higher Education Institutions
BAP Research Project, Ege University, Turkey